IDXX rides on strong CAG Diagnostics momentum and growing global software adoption, but currency pressure and solvency risks cloud the outlook.
Coalescence Partners Investment Management LP decreased its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 50.8% during the third quarter, according to the company in its most recent filing wi
MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, an
WESTBROOK, Maine--(BUSINESS WIRE)--ImageVue DR50 Plus introduces high-definition diagnostic imaging at the lowest dose of radiation, accelerating diagnosis and improving staff safety.
WESTBROOK, Maine--(BUSINESS WIRE)--Cancer Dx Panel expansion and inVue Dx FNA cytology rollout advance veterinary cancer care, enabling comprehensive mast cell tumor testing for dogs.

IDEXX Announces CEO Succession

08:30am, Tuesday, 13'th Jan 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President an
Commonwealth Equity Services LLC lowered its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.9% in the undefined quarter, according to its most recent disclosure with the Securities
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial r
CNBC's “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.
IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.
Railway Pension Investments Ltd raised its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 92.1% in the undefined quarter, according to the company in its most recent disclosure with
Gateway Investment Advisers LLC cut its position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 19.9% in the undefined quarter, according to the company in its most recent disclosure with the
IDEXX Laboratories, Inc. (NASDAQ: IDXX - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. Fou
NVIDIA, IDXX and Microsoft shine on ESG metrics, fueling investor interest with strong returns and ambitious 2030 goals.
Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE